Meningococcal disease

General Information

Meningococcal disease is caused by various serogroups of Neisseria meningitidis (N. meningitidis), of which groups A, B, C, W, Y account for about 95% of meningococcal disease. N. meningitidis is one of the most common causes of bacterial meningitis in the world and the only bacterium capable of generating large epidemics of meningitis.

Transmission

Meningococcus is transmitted by aerosol or direct contact with respiratory secretions of patients or healthy human carriers.

Symptoms

Meningitis and sepsis are the major clinical features of infection with N. meningitidis. Meningitis frequently presents with fever, headache and neck stiffness, and is often accompanied by other symptoms, such as altered mental status, nausea, vomiting and photophobia. Meningococcal sepsis is characterised by fever and a purpuric rash, often accompanied by septic shock, disseminated intravascular coagulation and multiple organ failure. Often a rapid progression of the disease, with an 8-15% case-fatality ratio. This may result in death within one or two days after onset of symptoms.

Epidemiology

2018

In 2018, 3,233 confirmed cases of invasive meningococcal disease (IMD), including 324 deaths, were reported in 30 EU/EEA Member States.​

Explosive epidemics with incidence rates of up to 1,000 cases per 100,000 inhabitants have been reported, particularly in sub-Saharan Africa.

MENINGOCOCCAL A, C, W, Y DISEASE

Vaccines Pipeline

1
Vaccines in
the pipeline

TECHNOLOGY PLATFORMS

Glycoconjugate vaccine (1)

DEVELOPMENT PHASES

Phase III (1)

TRIAL POPULATION

Paediatric (1)​

MENINGOCOCCAL A, B, C, W, Y DISEASE

Vaccines Pipeline

3
Vaccines in
the pipeline

TECHNOLOGY PLATFORMS

Multiple platforms (3)

DEVELOPMENT PHASES

Phase II (2)
Regulatory review (1)

TRIAL POPULATION

Paediatric + Adults (3)

Source:
WHO. Meningitis. Available from: https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/meningitis.
ECDC. Meningococcal disease. 2023. Available from: https://www.ecdc.europa.eu/en/meningococcaldisease.
ECDC. Invasive meningococcal disease. Annual Epidemiological Report for 2022. 2024. Available from: https://www.ecdc.europa.eu/en/publications-data/invasive-meningococcal-disease-annual-epidemiological-report-2022.
[Accessed: August 2024]